rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - Αρθρίτιδα, ρευματοειδή - Ανοσοκατασταλτικά - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
chirocaine in.so.cr 5mg/ml
abbvie b.v., the netherlands wegallan 9, 2132 jd hoofddorp - levobupivacaine hydrochloride - in.so.cr (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ Ή ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΔΙΑΛΥΜΑΤΟΣ ΠΡΟΣ ΕΓΧΥΣΗ) - 5mg/ml - levobupivacaine hydrochloride 5mg - levobupivacaine
zemplar 4mcg/cap soft.caps
abbott laboratories ΕΛΛΑΣ ΑΒΕΕ - paricalcitol - ΚΑΨΑΚΙΟ, ΜaΛΑΚΟ - 4mcg/cap - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
klaricid od con.r.tab 500mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - clarithromycin - con.r.tab (ΔΙΣΚΙΟ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - 500mg/tab - clarithromycin 500mg - clarithromycin
klaricid f.c.tab 250mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - clarithromycin - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 250mg/tab - clarithromycin 250mg - clarithromycin
klaricid f.c.tab 500mg/tab
viatris healthcare limited, ireland damastown industrial park, - dublin - clarithromycin - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 500mg/tab - clarithromycin 500mg - clarithromycin
klaricid gra.or.sus 250mg/5ml
viatris healthcare limited, ireland damastown industrial park, - dublin - clarithromycin - gra.or.sus (ΚΟΚΚΙΑ ΓΙΑ ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 250mg/5ml - clarithromycin 50mg - clarithromycin
ρυθμονορμ sr pr.cap 225mg/cap
bgp ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. bgp ΠΡΟΪΟΝΤΑ Μ.Ε.Π.Ε. Αγ. Δημητρίου 63, 174 56 Αλιμος 210.9891777 & 9891761 - propafenone hydrochloride - pr.cap (ΚΑΨΑΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ, ΣΚΛΗΡΟ) - 225mg/cap - propafenone hydrochloride 225mg - propafenone
ρυθμονορμ sr pr.cap 325mg/cap
bgp ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. bgp ΠΡΟΪΟΝΤΑ Μ.Ε.Π.Ε. Αγ. Δημητρίου 63, 174 56 Αλιμος 210.9891777 & 9891761 - propafenone hydrochloride - pr.cap (ΚΑΨΑΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ, ΣΚΛΗΡΟ) - 325mg/cap - propafenone hydrochloride 325mg - propafenone
ρυθμονορμ sr pr.cap 425mg/cap
bgp ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. bgp ΠΡΟΪΟΝΤΑ Μ.Ε.Π.Ε. Αγ. Δημητρίου 63, 174 56 Αλιμος 210.9891777 & 9891761 - propafenone hydrochloride - pr.cap (ΚΑΨΑΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ, ΣΚΛΗΡΟ) - 425mg/cap - propafenone hydrochloride 425mg - propafenone